Media Summary: Some parts of the webinar are missing due to some technical issues during recording. We apologize for this issue. Application: ... Welcome to our first installment of our presidential Jill Evanko has served as President and CEO of Chart Industries since June of 2018. Through her leadership, Chart has become ...

Discovery To Commercialization Speaker Series January 2021 - Detailed Analysis & Overview

Some parts of the webinar are missing due to some technical issues during recording. We apologize for this issue. Application: ... Welcome to our first installment of our presidential Jill Evanko has served as President and CEO of Chart Industries since June of 2018. Through her leadership, Chart has become ... Nabil Ullah, Investment analyst, and Matt Cohen, Ph.D., Managing Partner, Life Sciences, at Osage University Partners speak on ... Download Your Free Chrome Extension of Seamless AI to 10x your sales now: ...

Photo Gallery

Discovery to Commercialization Speaker Series - January 2021
Discovery to Commercialization Speaker Series - November 2020
Discovery to Commercialization Speaker Series - September 2020
From Discovery to Commercialization in Cell and Gene Therapy
Commercialization: Translating discovery into impact | 2023 State of the School of Medicine
Partnership With Discovery
Presidential Speaker Series: Open Source Drug Discovery
Discovery acquires Scripps for $14.6B
Discovery Parks Vancouver Commercialization Centre
Key Issues for Pharma - Drug Discovery
Dean's Speaker Series | Jill Evanko | CEO, Chart Industries
Penn Medicine Commercialization Speaker Series Fall 2022: Founder's Equity for University Startups
Sponsored
Sponsored
View Detailed Profile
Discovery to Commercialization Speaker Series - January 2021

Discovery to Commercialization Speaker Series - January 2021

On

Discovery to Commercialization Speaker Series - November 2020

Discovery to Commercialization Speaker Series - November 2020

On

Sponsored
Discovery to Commercialization Speaker Series - September 2020

Discovery to Commercialization Speaker Series - September 2020

On September 24, 2020 the

From Discovery to Commercialization in Cell and Gene Therapy

From Discovery to Commercialization in Cell and Gene Therapy

Some parts of the webinar are missing due to some technical issues during recording. We apologize for this issue. Application: ...

Commercialization: Translating discovery into impact | 2023 State of the School of Medicine

Commercialization: Translating discovery into impact | 2023 State of the School of Medicine

Allowing us to translate

Sponsored
Partnership With Discovery

Partnership With Discovery

Montgomery College's

Presidential Speaker Series: Open Source Drug Discovery

Presidential Speaker Series: Open Source Drug Discovery

Welcome to our first installment of our presidential

Discovery acquires Scripps for $14.6B

Discovery acquires Scripps for $14.6B

FBN's Dagen McDowell on the deal for

Discovery Parks Vancouver Commercialization Centre

Discovery Parks Vancouver Commercialization Centre

Mark Betteridge gives an overview of the

Key Issues for Pharma - Drug Discovery

Key Issues for Pharma - Drug Discovery

Link to this course: ...

Dean's Speaker Series | Jill Evanko | CEO, Chart Industries

Dean's Speaker Series | Jill Evanko | CEO, Chart Industries

Jill Evanko has served as President and CEO of Chart Industries since June of 2018. Through her leadership, Chart has become ...

Penn Medicine Commercialization Speaker Series Fall 2022: Founder's Equity for University Startups

Penn Medicine Commercialization Speaker Series Fall 2022: Founder's Equity for University Startups

Nabil Ullah, Investment analyst, and Matt Cohen, Ph.D., Managing Partner, Life Sciences, at Osage University Partners speak on ...

Why Discovery Meetings Are Killing Your Sales in 2026

Why Discovery Meetings Are Killing Your Sales in 2026

Download Your Free Chrome Extension of Seamless AI to 10x your sales now: ...

Discovery CEO: We have a library as big as Netflix that's fresh and unlike anyone else's

Discovery CEO: We have a library as big as Netflix that's fresh and unlike anyone else's

David Zaslav,

Discovery Inc. CEO: We're different than the competitive media aggregators

Discovery Inc. CEO: We're different than the competitive media aggregators

CNBC's Julia Boorstin interviews